Dexamethasone for Severe Hospital-Acquired Pneumonia with Inflammation
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether adding the anti-inflammatory drug dexamethasone to standard antibiotics improves recovery from severe hospital-acquired pneumonia in critically ill patients on a ventilator.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung infection that started in the hospital (at least 2 days after being admitted).
- You are on a breathing machine and have low oxygen levels (PaO2/FiO2 < 300).
- You have a high level of inflammation in your blood (CRP ≥ 150 mg/L).
- You have started antibiotics for this pneumonia less than 2 days ago.
- You are not pregnant, breastfeeding, or taking long-term steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving steroids early to people hospitalized with severe flu pneumonia can improve recovery and reduce complications. It may help by reducing lung inflammation.
This trial studies whether dexamethasone (a steroid medicine) improves outcomes in adults who have sudden, severe breathing failure caused by an infection while they are on a breathing machine. It may help reduce inflammation in the lungs during critical illness.
This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.
This trial tests whether dexamethasone (a steroid) can help people hospitalized with severe flu recover faster. It is for adults who are already taking Tamiflu and do not have other serious infections like COVID-19.
This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.
This trial tests if anti-inflammatory drugs tailored to specific germs can help patients in the ICU with severe community-acquired pneumonia recover faster. You may be eligible if you've been in the ICU less than 48 hours and meet certain diagnostic criteria.
Hear when a new Hospital-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.